Comment on “Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study” - Lou, Fu; Fan, Xiaohong (Journal of the Formosan Medical Association, 2025)